aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator...
10 insider purchases on record · latest filing 2026-05-28.
Insiders have also filed 9 sale transactions at ATYR.